LASABSELASA SUPERGENERICS LTD· Pharmaceuticals & BiotechnologyMinimalNeutral
Announced Mon, 19 Oct, 2026 · 17:25 IST

Routine Reg 74(5) compliance certificate for Sep 2026 quarter

LASA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
₹4.91
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-3.6%—
Pharmaceuticals peers, median of 173sector-2.2%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-2.6—-1.7—
Next day
—-3.6—-2.2—
2d
—-5.8—-3.4—
3d
-4.9-5.5+0.6-2.3-2.5
4d
—-3.8—-1.2—
5d
—-3.8—+0.2—
1w
———-1.2—
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lasa Supergenerics filed a quarterly certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026, submitted by its registrar Bigshare Services. The certificate confirms that dematerialisation requests received from depository participants were processed within 15 days, old share certificates were mutilated and cancelled, and the depository's name was substituted as registered owner in the company's register of members. This is a standard regulatory compliance filing.

Likely market impact

Routine compliance filing with no business or financial impact on shareholders.